1) Prof @chrystalpaulos.bsky.social @ #Emory @emoryuniversity.bsky.social talks how #B_cells play important role in #cancer #immunotherapy / @lesinskilab.bsky.social #Bridge2024 @sitcancer.bsky.social #FinishCancer
December 4, 2024 at 2:13 PM
1) Prof @chrystalpaulos.bsky.social @ #Emory @emoryuniversity.bsky.social talks how #B_cells play important role in #cancer #immunotherapy / @lesinskilab.bsky.social #Bridge2024 @sitcancer.bsky.social #FinishCancer
2) Prof @chrystalpaulos.bsky.social @ #Emory @emoryuniversity.bsky.social talks how #B_cells & #SEMA4D play important role in #cancer #immunotherapy / @lesinskilab.bsky.social #Bridge2024 @sitcancer.bsky.social #FinishCancer #Vaccinex
December 4, 2024 at 2:17 PM
2) Prof @chrystalpaulos.bsky.social @ #Emory @emoryuniversity.bsky.social talks how #B_cells & #SEMA4D play important role in #cancer #immunotherapy / @lesinskilab.bsky.social #Bridge2024 @sitcancer.bsky.social #FinishCancer #Vaccinex
3) Prof @chrystalpaulos.bsky.social @ #Emory @emoryuniversity.bsky.social talks how #B_cells & #SEMA4D play important role in #cancer #immunotherapy / @lesinskilab.bsky.social #Bridge2024 @sitcancer.bsky.social #FinishCancer #Vaccinex
December 4, 2024 at 2:18 PM
3) Prof @chrystalpaulos.bsky.social @ #Emory @emoryuniversity.bsky.social talks how #B_cells & #SEMA4D play important role in #cancer #immunotherapy / @lesinskilab.bsky.social #Bridge2024 @sitcancer.bsky.social #FinishCancer #Vaccinex
Breakthrough in Poultry Immunology: Discovering Novel B Cell Pathways in Chickens#Japan#B_Cells#Sendai#IGA#chicken_immunology
Breakthrough in Poultry Immunology: Discovering Novel B Cell Pathways in Chickens
Researchers make a significant discovery about chicken immunology, revealing new pathways for B cell differentiation and their role in gut health.
third-news.com
July 17, 2026 at 3:25 AM
Breakthrough in Poultry Immunology: Discovering Novel B Cell Pathways in Chickens#Japan#B_Cells#Sendai#IGA#chicken_immunology
Revolutionary Progress in Gene Therapy with Immusoft's Patient Re-dosing of ISP-001 for MPS I#USA#San_Francisco#Immusoft#B_Cells#ISP-001
Revolutionary Progress in Gene Therapy with Immusoft's Patient Re-dosing of ISP-001 for MPS I
Immusoft has made a groundbreaking advance in gene therapy by successfully re-dosing a patient with ISP-001 for MPS I, showcasing excellent tolerability and safety.
third-news.com
October 7, 2025 at 12:43 PM
Revolutionary Progress in Gene Therapy with Immusoft's Patient Re-dosing of ISP-001 for MPS I#USA#San_Francisco#Immusoft#B_Cells#ISP-001
Immusoft to Showcase Groundbreaking Results on Engineered B Cells at ASGCT 2025 Conference#USA#New_Orleans#Immusoft#B_Cells#MPS_I
Immusoft to Showcase Groundbreaking Results on Engineered B Cells at ASGCT 2025 Conference
Immusoft is set to present pivotal clinical trial results for engineered B cells aimed at treating MPS I, showcasing innovations in cell therapy.
third-news.com
May 13, 2025 at 12:47 PM
Immusoft to Showcase Groundbreaking Results on Engineered B Cells at ASGCT 2025 Conference#USA#New_Orleans#Immusoft#B_Cells#MPS_I
Immusoft to Showcase Promising Data from Engineered B Cell Therapy at WORLDSymposium 2025#United_States#San_Diego#Immusoft#B_Cells#MPS_I
Immusoft to Showcase Promising Data from Engineered B Cell Therapy at WORLDSymposium 2025
Immusoft Corporation is set to present groundbreaking findings from its pioneering clinical trial of engineered B cells at WORLDSymposium 2025, promising new treatment avenues.
third-news.com
January 27, 2025 at 2:21 PM
Immusoft to Showcase Promising Data from Engineered B Cell Therapy at WORLDSymposium 2025#United_States#San_Diego#Immusoft#B_Cells#MPS_I